171 related articles for article (PubMed ID: 21737806)
1. Atherogenic dyslipidemia in patients with transient ischemic attack.
Sirimarco G; Deplanque D; Lavallée PC; Labreuche J; Meseguer E; Cabrejo L; Guidoux C; Olivot JM; Abboud H; Lapergue B; Klein IF; Mazighi M; Touboul PJ; Bruckert E; Amarenco P
Stroke; 2011 Aug; 42(8):2131-7. PubMed ID: 21737806
[TBL] [Abstract][Full Text] [Related]
2. Atherogenic Dyslipidemia and Residual Vascular Risk After Stroke or Transient Ischemic Attack.
Hoshino T; Ishizuka K; Toi S; Mizuno T; Nishimura A; Takahashi S; Wako S; Kitagawa K
Stroke; 2022 Jan; 53(1):79-86. PubMed ID: 34470483
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease.
Arca M; Montali A; Valiante S; Campagna F; Pigna G; Paoletti V; Antonini R; Barillà F; Tanzilli G; Vestri A; Gaudio C
Am J Cardiol; 2007 Nov; 100(10):1511-6. PubMed ID: 17996510
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients.
Sirimarco G; Labreuche J; Bruckert E; Goldstein LB; Fox KM; Rothwell PM; Amarenco P;
Stroke; 2014 May; 45(5):1429-36. PubMed ID: 24736236
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
[TBL] [Abstract][Full Text] [Related]
6. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
7. Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.
Saposnik G; Fonarow GC; Pan W; Liang L; Hernandez AF; Schwamm LH; Smith EE;
Stroke; 2014 Nov; 45(11):3343-51. PubMed ID: 25300975
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of dyslipidemia and associated risk factors in Turkish adults.
Bayram F; Kocer D; Gundogan K; Kaya A; Demir O; Coskun R; Sabuncu T; Karaman A; Cesur M; Rizzo M; Toth PP; Gedik V
J Clin Lipidol; 2014; 8(2):206-16. PubMed ID: 24636181
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria.
Olamoyegun MA; Oluyombo R; Asaolu SO
Ann Afr Med; 2016; 15(4):194-199. PubMed ID: 27853034
[TBL] [Abstract][Full Text] [Related]
10. Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Amarenco P; Goldstein LB; Callahan A; Sillesen H; Hennerici MG; O'Neill BJ; Rudolph AE; Simunovic L; Zivin JA; Welch KM;
Atherosclerosis; 2009 Jun; 204(2):515-20. PubMed ID: 18962621
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study.
Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C
BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902
[TBL] [Abstract][Full Text] [Related]
12. Dyslipidemia and its association with meibomian gland dysfunction.
Braich PS; Howard MK; Singh JS
Int Ophthalmol; 2016 Aug; 36(4):469-76. PubMed ID: 26515235
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Cardiorespiratory Fitness Levels on the Risk of Developing Atherogenic Dyslipidemia.
Breneman CB; Polinski K; Sarzynski MA; Lavie CJ; Kokkinos PF; Ahmed A; Sui X
Am J Med; 2016 Oct; 129(10):1060-6. PubMed ID: 27288861
[TBL] [Abstract][Full Text] [Related]
14. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
Wong ND; Chuang J; Zhao Y; Rosenblit PD
J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
[TBL] [Abstract][Full Text] [Related]
15. Association between atherogenic dyslipidemia and recurrent stroke risk in patients with different subtypes of ischemic stroke.
Zhao L; Wang R; Song B; Tan S; Gao Y; Fang H; Lu J; Xu Y
Int J Stroke; 2015 Jul; 10(5):752-8. PubMed ID: 25924059
[TBL] [Abstract][Full Text] [Related]
16. Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients.
Ovbiagele B; Hills NK; Saver JL; Johnston SC;
J Hosp Med; 2006 Jul; 1(4):214-20. PubMed ID: 17219502
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care.
Bestehorn K; Smolka W; Pittrow D; Schulte H; Assmann G
Curr Med Res Opin; 2010 Dec; 26(12):2833-9. PubMed ID: 21058895
[TBL] [Abstract][Full Text] [Related]
18. Atherogenic dyslipidemia in patients with established coronary artery disease.
Lahoz C; Mostaza JM; Tranche S; Martin-Jadraque R; Mantilla MT; López-Rodriguez I; Monteiro B; Sanchez-Zamorano MA; Taboada M
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):103-8. PubMed ID: 20675108
[TBL] [Abstract][Full Text] [Related]
19. Lipoprotein profile in patients who survive a stroke.
Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
[TBL] [Abstract][Full Text] [Related]
20. The Atherogenic Index of Plasma is Independently Associated with Symptomatic Carotid Artery Stenosis.
Garg R; Knox N; Prasad S; Zinzuwadia S; Rech MA
J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105351. PubMed ID: 33045624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
